ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas	Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma	Recruiting	Phase 2	2024-08-23		NCT05830123

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hansoh BioMedical R&D Company	37

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chinese PLA General Hospital of Eastern Theater Command	Nanjing	China	1
First Affiliated Hospital, Sun Yat-Sen University	Guangzhou	China	2
Henan Cancer Hospital	Zhengzhou	China	60
Hunan Cancer Hospital	Changsha	China	47
Peking University People's Hospital	Beijing	China	68
Second Affiliated Hospital, School of Medicine, Zhejiang University	Hangzhou	China	1
Shanghai 6th People's Hospital	Shanghai	China	2
Shanghai General Hospital	Shanghai	China	35
Sun Yat-Sen University Cancer Center	Guangzhou	China	66
Tianjin Cancer Hospital	Tianjin	China	10
Zhejiang Cancer Hospital	Hangzhou	China	40